6.
Joubert M, Eisenring J, Robb J, Andermann F
. Familial agenesis of the cerebellar vermis. A syndrome of episodic hyperpnea, abnormal eye movements, ataxia, and retardation. Neurology. 1969; 19(9):813-25.
DOI: 10.1212/wnl.19.9.813.
View
7.
Day J, Ricker K, Jacobsen J, Rasmussen L, Dick K, Kress W
. Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology. 2003; 60(4):657-64.
DOI: 10.1212/01.wnl.0000054481.84978.f9.
View
8.
Koerner F, Schlote W
. Chronic progressive external ophthalmoplegia: association with retinal pigmentary changes and evidence in favor of ocular myopathy. Arch Ophthalmol. 1972; 88(2):155-66.
DOI: 10.1001/archopht.1972.01000030157005.
View
9.
Elmonem M, Veys K, Soliman N, Van Dyck M, Van den Heuvel L, Levtchenko E
. Cystinosis: a review. Orphanet J Rare Dis. 2016; 11:47.
PMC: 4841061.
DOI: 10.1186/s13023-016-0426-y.
View
10.
Luis L, Costa J, Munoz E, De Carvalho M, Carmona S, Schneider E
. Vestibulo-ocular reflex dynamics with head-impulses discriminates spinocerebellar ataxias types 1, 2 and 3 and Friedreich ataxia. J Vestib Res. 2016; 26(3):327-34.
DOI: 10.3233/VES-160579.
View
11.
Wanders R, Jansen G, Skjeldal O
. Refsum disease, peroxisomes and phytanic acid oxidation: a review. J Neuropathol Exp Neurol. 2001; 60(11):1021-31.
DOI: 10.1093/jnen/60.11.1021.
View
12.
Ashizawa T, Figueroa K, Perlman S, Gomez C, Wilmot G, Schmahmann J
. Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study. Orphanet J Rare Dis. 2013; 8:177.
PMC: 3843578.
DOI: 10.1186/1750-1172-8-177.
View
13.
Udd B, Meola G, Krahe R, Thornton C, Ranum L, Bassez G
. 140th ENMC International Workshop: Myotonic Dystrophy DM2/PROMM and other myotonic dystrophies with guidelines on management. Neuromuscul Disord. 2006; 16(6):403-13.
DOI: 10.1016/j.nmd.2006.03.010.
View
14.
Cook A, Giunti P
. Friedreich's ataxia: clinical features, pathogenesis and management. Br Med Bull. 2017; 124(1):19-30.
PMC: 5862303.
DOI: 10.1093/bmb/ldx034.
View
15.
Horster F, Baumgartner M, Viardot C, Suormala T, Burgard P, Fowler B
. Long-term outcome in methylmalonic acidurias is influenced by the underlying defect (mut0, mut-, cblA, cblB). Pediatr Res. 2007; 62(2):225-30.
DOI: 10.1203/PDR.0b013e3180a0325f.
View
16.
Voermans N, Erasmus C, Ockeloen C, van Engelen B, Eggink C
. Primary cataract as a key to recognition of myotonic dystrophy type 1. Eur J Ophthalmol. 2015; 25(4):e46-9.
DOI: 10.5301/ejo.5000565.
View
17.
Yazdani M
. Cellular and Molecular Responses to Mitochondrial DNA Deletions in Kearns-Sayre Syndrome: Some Underlying Mechanisms. Mol Neurobiol. 2024; 61(8):5665-5679.
DOI: 10.1007/s12035-024-03938-7.
View
18.
Valente E, Dallapiccola B, Bertini E
. Joubert syndrome and related disorders. Handb Clin Neurol. 2013; 113:1879-88.
DOI: 10.1016/B978-0-444-59565-2.00058-7.
View
19.
Reisser C, Kimberling W, Otterstedde C
. Hearing loss in Usher syndrome type II is nonprogressive. Ann Otol Rhinol Laryngol. 2002; 111(12 Pt 1):1108-11.
DOI: 10.1177/000348940211101208.
View
20.
Santavuori P, Haltia M, Rapola J
. Infantile type of so-called neuronal ceroid-lipofuscinosis. Dev Med Child Neurol. 1974; 16(5):644-53.
DOI: 10.1111/j.1469-8749.1974.tb04183.x.
View